Chief Complaint

Follow-up for type 2 diabetes and stage 2 hypertension; blurry vision and difficulty reading fine print for the past month

HPI

41-year-old female with type 2 diabetes and stage 2 hypertension presents for follow-up. She reports blurry vision and difficulty reading fine print over the past month. She denies eye pain or flashes of light.

Review of Systems

Vision: Blurry vision, difficulty reading fine print; denies eye pain or flashes.

Physical Exam

Vital Signs: Blood pressure 150/95 mmHg (elevated).

Assessment

This is a 41-year-old female with established type 2 diabetes mellitus and stage 2 hypertension presenting for routine follow-up, now reporting concerning visual symptoms. She describes blurry vision and difficulty reading fine print over the past month without associated eye pain or photopsias, raising concern for diabetic retinopathy given her diabetes history and new visual changes.

Today's blood pressure is 150/95 mmHg, indicating inadequate blood pressure control and confirming stage 2 hypertension. She is currently on metformin for diabetes management and lisinopril for hypertension.

The combination of diabetes, uncontrolled hypertension, and new visual changes necessitates urgent ophthalmologic evaluation to assess for diabetic retinopathy, macular edema, or other diabetes-related ocular complications. Additionally, glycemic control should be assessed with HbA1c testing, as hyperglycemia itself can cause refractive changes and contribute to microvascular complications.

Plan

1. Diabetes Management:

   • Continue metformin at current dose
   • Order HbA1c to assess glycemic control and guide further diabetes management
   • Results will inform whether medication intensification is needed

2. Hypertension Management:

   • Continue lisinopril at current dose
   • Blood pressure remains elevated at 150/95 mmHg despite therapy; will reassess at next visit and consider dose adjustment or addition of second antihypertensive agent based on home readings and response

3. Vision Changes/Diabetic Retinopathy Screening:

   • Refer to ophthalmology for comprehensive dilated eye examination to evaluate for diabetic retinopathy, macular edema, or other causes of visual changes
   • Visual symptoms in the setting of diabetes warrant urgent ophthalmologic assessment

4. Follow-up:

   • Return in 4-6 weeks to review HbA1c results and ophthalmology findings
   • Bring home blood pressure log if available
   • Patient instructed to seek urgent care for any sudden vision loss, severe eye pain, or floaters